These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 7960244)

  • 1. Protracted treatment with phorbol ester modulates J-7 human hepatoma-cell-induced aggregation and coagulation of human platelet-rich plasma.
    Ko FN; Yu SM; Teng CM
    Int J Cancer; 1994 Dec; 59(5):706-11. PubMed ID: 7960244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Triflavin, an Arg-Gly-Asp containing snake venom peptide, inhibits aggregation of human platelets induced by human hepatoma cell line.
    Sheu JR; Lin CH; Chung JL; Teng CM; Huang TF
    Thromb Res; 1992 Jun; 66(6):679-91. PubMed ID: 1519227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Triflavin, an Arg-Gly-Asp-containing peptide, inhibits tumor cell-induced platelet aggregation.
    Sheu JR; Lin CH; Peng HC; Teng CM; Huang TF
    Jpn J Cancer Res; 1993 Oct; 84(10):1062-71. PubMed ID: 8226281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Arg-Gly-Asp-containing peptide, rhodostomin, inhibits in vitro cell adhesion to extracellular matrices and platelet aggregation caused by saos-2 human osteosarcoma cells.
    Chiang HS; Yang RS; Huang TF
    Br J Cancer; 1995 Feb; 71(2):265-70. PubMed ID: 7841039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of platelet aggregation induced by human breast carcinoma and its inhibition by snake venom peptides, trigramin and rhodostomin.
    Chiang HS; Swaim MW; Huang TF
    Breast Cancer Res Treat; 1995 Mar; 33(3):225-35. PubMed ID: 7749150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of platelet aggregation induced by human colon adenocarcinoma cells and its inhibition by snake venom peptides, trigramin and rhodostomin.
    Chiang HS; Swaim MW; Huang TF
    Br J Haematol; 1994 Jun; 87(2):325-31. PubMed ID: 7947275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet aggregation induced by alpha 2-adrenoceptor and protein kinase C activation. A novel synergism.
    Siess W; Lapetina EG
    Biochem J; 1989 Oct; 263(2):377-85. PubMed ID: 2574568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Daphnoretin, a new protein kinase C activator isolated from Wikstroemia indica C.A. Mey.
    Ko FN; Chang YL; Kuo YH; Lin YL; Teng CM
    Biochem J; 1993 Oct; 295 ( Pt 1)(Pt 1):321-7. PubMed ID: 8216237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterisation of platelet aggregation induced by PC-3 human prostate adenocarcinoma cells and inhibited by venom peptides, trigramin and rhodostomin.
    Swaim MW; Chiang HS; Huang TF
    Eur J Cancer; 1996 Apr; 32A(4):715-21. PubMed ID: 8695278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Staurosporine up-regulates the expression of phorbol dibutyrate binding sites in human platelets.
    Rais S; Combadiere C; Hakim J; Perianin A
    Biochem Pharmacol; 1994 May; 47(10):1797-804. PubMed ID: 8204096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dependence of human platelet functional responses on divalent cations: aggregation and secretion in heparin- and hirudin-anticoagulated platelet-rich plasma and the effects of chelating agents.
    Lages B; Weiss HJ
    Thromb Haemost; 1981 Apr; 45(2):173-9. PubMed ID: 6789496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ca2+ mobilization primes protein kinase C in human platelets. Ca2+ and phorbol esters stimulate platelet aggregation and secretion synergistically through protein kinase C.
    Siess W; Lapetina EG
    Biochem J; 1988 Oct; 255(1):309-18. PubMed ID: 3143357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on tumor-cell-induced platelet aggregation in human lung cancer cell lines.
    Heinmöller E; Weinel RJ; Heidtmann HH; Salge U; Seitz R; Schmitz I; Müller KM; Zirngibl H
    J Cancer Res Clin Oncol; 1996; 122(12):735-44. PubMed ID: 8954171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma-dependent and -independent mechanisms of platelet aggregation induced by human tumour cell lines.
    Scarlett JD; Thurlow PJ; Connellan JM; Louis CJ
    Thromb Res; 1987 Jun; 46(5):715-26. PubMed ID: 3629545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of thrombin in ADP-induced platelet aggregation and release: a critical evaluation.
    Macfarlane DE; Walsh PN; Mills DC; Holmsen H; Day HJ
    Br J Haematol; 1975 Aug; 30(4):457-63. PubMed ID: 811245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Procoagulant activity of the MC28 fibrosarcoma cell line in vitro and in vivo.
    Amirkhosravi M; Francis JL
    Br J Haematol; 1993 Dec; 85(4):736-44. PubMed ID: 7918038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fusaric acid, a mycotoxin, and its influence on blood coagulation and platelet function.
    Devaraja S; Girish KS; Santhosh MS; Hemshekhar M; Nayaka SC; Kemparaju K
    Blood Coagul Fibrinolysis; 2013 Jun; 24(4):419-23. PubMed ID: 23343693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Triflavin, an antiplatelet peptide, inhibits tumor cell-extracellular matrix adhesion through an arginine-glycine-aspartic acid-dependent mechanism.
    Sheu JR; Lin CH; Huang TF
    J Lab Clin Med; 1994 Feb; 123(2):256-63. PubMed ID: 8301202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of platelet activation by cultured human cancer cells and cells freshly isolated from tumor tissues.
    Grignani G; Pacchiarini L; Ricetti MM; Dionigi P; Jemos V; Zucchella M; Fratino P
    Invasion Metastasis; 1989; 9(5):298-309. PubMed ID: 2767927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor cell-induced platelet aggregation in vitro by human pancreatic cancer cell lines.
    Heinmöller E; Schropp T; Kisker O; Simon B; Seitz R; Weinel RJ
    Scand J Gastroenterol; 1995 Oct; 30(10):1008-16. PubMed ID: 8545606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.